Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Take part in the Grand Challenges in Global Eye Health study.

Ramke J, Faal H, Burton M.

Community Eye Health. 2019;32(106):36. No abstract available.

2.

Announcing The Lancet Global Health Commission on Global Eye Health.

Burton MJ, Faal HB, Ramke J, Ravilla T, Holland P, Wang N, West SK, Bourne RRA, Congdon NG, Foster A.

Lancet Glob Health. 2019 Dec;7(12):e1612-e1613. doi: 10.1016/S2214-109X(19)30450-4. Epub 2019 Oct 9. No abstract available.

3.

Strengths, challenges and opportunities of implementing primary eye care in Nigeria.

Aghaji AE, Gilbert C, Ihebuzor N, Faal H.

BMJ Glob Health. 2018 Dec 14;3(6):e000846. doi: 10.1136/bmjgh-2018-000846. eCollection 2018. No abstract available.

4.

Process evaluation of a National Primary Eye Care Programme in Rwanda.

Yip JLY, Bright T, Ford S, Mathenge W, Faal H; Rwanda Primary Eye Care Process evaluation group.

BMC Health Serv Res. 2018 Dec 7;18(1):950. doi: 10.1186/s12913-018-3718-1.

5.

The Streptococcus pyogenes fibronectin/tenascin-binding protein PrtF.2 contributes to virulence in an influenza superinfection.

Herrera AL, Faal H, Moss D, Addengast L, Fanta L, Eyster K, Huber VC, Chaussee MS.

Sci Rep. 2018 Aug 14;8(1):12126. doi: 10.1038/s41598-018-29714-x.

6.

Nigeria normative data for defining glaucoma in prevalence surveys.

Kyari F, Abdull MM, Sallo FB, Spry PG, Wormald R, Peto T, Faal HB, Gilbert CE; Nigeria National Blindness and Visual Impairment Study Group.

Ophthalmic Epidemiol. 2015 Apr;22(2):98-108. doi: 10.3109/09286586.2015.1012268.

PMID:
25777309
7.

Neglected communities.

Faal H.

Community Eye Health. 2013;26(82):24-5. No abstract available.

8.

Epidemiology of glaucoma in sub-saharan Africa: prevalence, incidence and risk factors.

Kyari F, Abdull MM, Bastawrous A, Gilbert CE, Faal H.

Middle East Afr J Ophthalmol. 2013 Apr-Jun;20(2):111-25. doi: 10.4103/0974-9233.110605. Review.

9.

Evidence for integrating eye health into primary health care in Africa: a health systems strengthening approach.

du Toit R, Faal HB, Etya'ale D, Wiafe B, Mason I, Graham R, Bush S, Mathenge W, Courtright P.

BMC Health Serv Res. 2013 Mar 18;13:102. doi: 10.1186/1472-6963-13-102. Review.

10.

Millennium development goals and eye health.

Faal HB.

Indian J Ophthalmol. 2012 Sep-Oct;60(5):411-5. doi: 10.4103/0301-4738.100538. Review.

11.

Review of the publications of the Nigeria national blindness survey: methodology, prevalence, causes of blindness and visual impairment and outcome of cataract surgery.

Rabiu MM, Kyari F, Ezelum C, Elhassan E, Sanda S, Murthy GV, Sivasubramaniam S, Glibert C, Abdull MM, Abiose A, Bankole O, Entekume G, Faal H, Imam A, Sang LP, Abubakar T.

Ann Afr Med. 2012 Jul-Sep;11(3):125-30. doi: 10.4103/1596-3519.96859. Review.

12.

Conversations with glaucoma patients.

Faal H.

Community Eye Health. 2012;25(79-80):54. No abstract available.

13.

Primary open-angle glaucoma: everyone's business.

Faal H.

Community Eye Health. 2012;25(79-80):41-3. No abstract available.

14.

Managing information in eye care programmes: the health systems perspective.

Faal H, Cook C, Thulasiraj R.

Community Eye Health. 2010 Dec;23(74):50-2. No abstract available.

15.

The challenge of uncorrected refractive error: driving the agenda of the Durban Declaration on refractive error and service development.

Naidoo KS, Wallace DB, Holden BA, Minto H, Faal HB, Dube P.

Clin Exp Optom. 2010 May;93(3):131-6. doi: 10.1111/j.1444-0938.2010.00455.x. Epub 2010 Mar 18. Review.

16.

Preventing corneal blindness: working with communities.

Faal H.

Community Eye Health. 2009 Dec;22(71):36-7. No abstract available.

17.

The Nigerian national blindness and visual impairment survey: Rationale, objectives and detailed methodology.

Dineen B, Gilbert CE, Rabiu M, Kyari F, Mahdi AM, Abubakar T, Ezelum CC, Gabriel E, Elhassan E, Abiose A, Faal H, Jiya JY, Ozemela CP, Lee PS, Gudlavalleti MV.

BMC Ophthalmol. 2008 Sep 22;8:17. doi: 10.1186/1471-2415-8-17.

18.

Convincing governments to act: VISION 2020 and the Millennium Development Goals.

Faal H, Gilbert C.

Community Eye Health. 2007 Dec;20(64):62-4. No abstract available.

19.

Reaching into the district: strengthening the eye care team.

Faal H.

Community Eye Health. 2004 Oct;17(51):36-7. No abstract available.

20.

The health for peace initiative in west Africa.

Faal H, Sillah A, Bah M.

Community Eye Health. 2006 Jun;19(58):24-6. No abstract available.

21.

How can we strengthen ophthalmic research in Africa?

Courtright P, Faal HB.

Can J Ophthalmol. 2006 Aug;41(4):424-5. No abstract available.

PMID:
16883358
22.

A proposed rapid methodology to assess the prevalence and causes of blindness and visual impairment.

Dineen B, Foster A, Faal H.

Ophthalmic Epidemiol. 2006 Feb;13(1):31-4.

PMID:
16510344
23.

The long-term natural history of trachomatous trichiasis in the Gambia.

Burton MJ, Bowman RJ, Faal H, Aryee EA, Ikumapayi UN, Alexander ND, Adegbola RA, Mabey DC, Foster A, Johnson GJ, Bailey RL.

Invest Ophthalmol Vis Sci. 2006 Mar;47(3):847-52.

24.

A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia.

Burton MJ, Kinteh F, Jallow O, Sillah A, Bah M, Faye M, Aryee EA, Ikumapayi UN, Alexander ND, Adegbola RA, Faal H, Mabey DC, Foster A, Johnson GJ, Bailey RL.

Br J Ophthalmol. 2005 Oct;89(10):1282-8.

25.

Types of Glaucoma and recent trends applied in treatment: Observations from a Glaucoma Training Workshop in the Gambia.

Chuka-Okosa CM, Faal HB, Ogunro A, Duke R.

Niger Postgrad Med J. 2005 Sep;12(3):203-9.

PMID:
16160723
26.

Long term outcome of trichiasis surgery in the Gambia.

Burton MJ, Bowman RJ, Faal H, Aryee EA, Ikumapayi UN, Alexander ND, Adegbola RA, West SK, Mabey DC, Foster A, Johnson GJ, Bailey RL.

Br J Ophthalmol. 2005 May;89(5):575-9.

27.

Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.

Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, Sillah A, Faal H, West SK, Foster A, Johnson GJ, Mabey DC, Bailey RL.

Lancet. 2005 Apr 9-15;365(9467):1321-8.

PMID:
15823382
28.

Analysis of costs and benefits of the Gambian Eye Care Program.

Frick KD, Foster A, Bah M, Faal H.

Arch Ophthalmol. 2005 Feb;123(2):239-43.

29.

VISION 2020: The Right to Sight: a global initiative to eliminate avoidable blindness.

Pizzarello L, Abiose A, Ffytche T, Duerksen R, Thulasiraj R, Taylor H, Faal H, Rao G, Kocur I, Resnikoff S.

Arch Ophthalmol. 2004 Apr;122(4):615-20. Review. No abstract available.

PMID:
15078680
30.

Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial.

Emerson PM, Lindsay SW, Alexander N, Bah M, Dibba SM, Faal HB, Lowe KO, McAdam KP, Ratcliffe AA, Walraven GE, Bailey RL.

Lancet. 2004 Apr 3;363(9415):1093-8.

PMID:
15064026
31.

Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages.

Burton MJ, Holland MJ, Faal N, Aryee EA, Alexander ND, Bah M, Faal H, West SK, Foster A, Johnson GJ, Mabey DC, Bailey RL.

Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4215-22.

PMID:
14507864
32.

Longitudinal study of trachomatous trichiasis in The Gambia: barriers to acceptance of surgery.

Bowman RJ, Faal H, Jatta B, Myatt M, Foster A, Johnson GJ, Bailey RL.

Invest Ophthalmol Vis Sci. 2002 Apr;43(4):936-40.

PMID:
11923231
33.

Non-trachomatous corneal opacities in the Gambia--aetiology and visual burden.

Bowman RJ, Faal H, Dolin P, Johnson GJ.

Eye (Lond). 2002 Jan;16(1):27-32.

34.

Longitudinal study of trachomatous trichiasis in the Gambia.

Bowman RJ, Faal H, Myatt M, Adegbola R, Foster A, Johnson GJ, Bailey RL.

Br J Ophthalmol. 2002 Mar;86(3):339-43.

35.

Natural history of trachomatous scarring in The Gambia: results of a 12-year longitudinal follow-up.

Bowman RJ, Jatta B, Cham B, Bailey RL, Faal H, Myatt M, Foster A, Johnson GJ.

Ophthalmology. 2001 Dec;108(12):2219-24.

PMID:
11733262
36.

Long-term follow-up of lid surgery for trichiasis in the Gambia: surgical success and patient perceptions.

Bowman RJ, Jatta B, Faal H, Bailey R, Foster A, Johnson GJ.

Eye (Lond). 2000 Dec;14(Pt 6):864-8.

PMID:
11584844
37.

Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.

Fraser-Hurt N, Bailey RL, Cousens S, Mabey D, Faal H, Mabey DC.

Bull World Health Organ. 2001;79(7):632-40.

38.

Understanding the community perspectives of trachoma: The Gambia as a case study.

Ajewole JF, Faal HB, Johnson G, Hart A.

Ophthalmic Epidemiol. 2001 Jul;8(2-3):163-80.

PMID:
11471086
39.

Operational comparison of single-dose azithromycin and topical tetracycline for trachoma.

Bowman RJ, Sillah A, Van Dehn C, Goode VM, Muqit MM, Johnson GJ, Milligan P, Rowley J, Faal H, Bailey RL.

Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4074-9. Erratum in: Invest Ophthalmol Vis Sci. 2007 Jul;48(7):2966. Muquit, M [corrected to Muqit, M M].

PMID:
11095598
40.

Should trichiasis surgery be offered in the village? A community randomised trial of village vs. health centre-based surgery.

Bowman RJ, Soma OS, Alexander N, Milligan P, Rowley J, Faal H, Foster A, Bailey RL, Johnson GJ.

Trop Med Int Health. 2000 Aug;5(8):528-33.

41.

Evaluation of a national eye care programme: re-survey after 10 years.

Faal H, Minassian DC, Dolin PJ, Mohamed AA, Ajewole J, Johnson GJ.

Br J Ophthalmol. 2000 Sep;84(9):948-51.

42.

Is there a role for glycosuria testing in sub-Saharan Africa?

van der Sande MA, Walraven GE, Bailey R, Rowley JT, Banya WA, Nyan OA, Faal H, Ceesay SM, Milligan PJ, McAdam KP.

Trop Med Int Health. 1999 Jul;4(7):506-13.

43.

Retinal manifestations of HIV-1 and HIV-2 infections among hospital patients in The Gambia, west Africa.

Jaffar S, Ariyoshi K, Frith P, Okouchi Y, Sabally S, Ajewole T, Bailey R, Lee PS, Corrah T, Johnson G, Faal H, Whittle H.

Trop Med Int Health. 1999 Jul;4(7):487-92.

44.

Azithromycin in control of trachoma.

Schachter J, West SK, Mabey D, Dawson CR, Bobo L, Bailey R, Vitale S, Quinn TC, Sheta A, Sallam S, Mkocha H, Mabey D, Faal H.

Lancet. 1999 Aug 21;354(9179):630-5.

PMID:
10466664
45.

Effect of fly control on trachoma and diarrhoea.

Emerson PM, Lindsay SW, Walraven GE, Faal H, B√łgh C, Lowe K, Bailey RL.

Lancet. 1999 Apr 24;353(9162):1401-3.

PMID:
10227221
46.

Trachoma in The Gambia.

Dolin PJ, Faal H, Johnson GJ, Ajewole J, Mohamed AA, Lee PS.

Br J Ophthalmol. 1998 Aug;82(8):930-3.

47.

Barriers to the uptake of cataract surgery.

Johnson JG, Goode Sen V, Faal H.

Trop Doct. 1998 Oct;28(4):218-20.

PMID:
9803842
48.

Nationwide prevalence study of hypertension and related non-communicable diseases in The Gambia.

van der Sande MA, Bailey R, Faal H, Banya WA, Dolin P, Nyan OA, Ceesay SM, Walraven GE, Johnson GJ, McAdam KP.

Trop Med Int Health. 1997 Nov;2(11):1039-48.

49.

Reduction of trachoma in a sub-Saharan village in absence of a disease control programme.

Dolin PJ, Faal H, Johnson GJ, Minassian D, Sowa S, Day S, Ajewole J, Mohamed AA, Foster A.

Lancet. 1997 May 24;349(9064):1511-2.

PMID:
9167460
50.

National survey of blindness and low vision in The Gambia: results.

Faal H, Minassian D, Sowa S, Foster A.

Br J Ophthalmol. 1989 Feb;73(2):82-7.

Supplemental Content

Support Center